PTSM: Pharmaceutical Technology Sourcing and Management, May 2, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, May 2, 2012
Biologics
White House Releases National Bioeconomy Blueprint
By Patricia Van Arnum
The Obama administration details five strategic imperatives to drive bioscience research as a means of economic growth.
Contract Services
CROs Urge for Modernization of Clinical Trials
By Patricia Van Arnum
Clinical research organizations see reform in clinical-trial process, including the establishment of chief innovation officer at FDA.
Outsourcing
Ways to Recover Lost Margins
By Gregg Brandyberry
Recovery audits and other past practices in procurement can improve the bottom line.
CSR and Sustainability Forum
The Marriage of Global Health and Sustainability
By Patricia Van Arnum
Industry leaders share their perspectives on how the pharmaceutical industry is and can further advance sustainability.
GlaxoSmithKline Outlines Its Sustainability Goals
By Patricia Van Arnum
The company provides progress made in 2011 and future environmental objectives.
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
22%
To all process for new products only
12%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Click here